B8FK (B8FK) News
Follow B8FK (B8FK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Biofrontera AG (B8FK) Turns H1 EBITDA Positive on 44% Revenue Growth
Biofrontera AG reported unaudited H1 2026 revenue of €9.0M, up 44% YoY, and EBITDA from continuing operations of €1.7M vs. -€1.3M. German sales rose 54% to €6.8M, aided by pre-price hike stocking; management expects this
EARNINGS | Sep 30, 2026, 11:31 AM UTC
H
Biofrontera AG (B8FK) H1 Revenue +44% To €9.0M; Profit €5.5M
Biofrontera AG reported unaudited H1 2026 revenue of €9.0M, up 44% YoY, EBITDA from continuing ops of €1.7M, and a total profit after tax of €5.5M versus a €3.7M loss in H1 2025. Guidance for 2026 was confirmed.Material
EARNINGS | Sep 30, 2026, 11:31 AM UTC
H
Biofrontera AG (B8FK) Sets H1 2026 Report Release Date
Biofrontera AG will disclose its Half Year 2026 financial report for the period 01.01.2026—30.06.2026 on Sept 30, 2026 via its website.Material DetailsContext by AI AnalystThis is a routine scheduling notice ahead of ear
EARNINGS | Sep 30, 2026, 10:46 AM UTC
H
Biofrontera AG (B8FK) To Publish H1 2026 Report Today
Biofrontera AG said its half-year 2026 report (01.01—30.06.2026) will be published on 30.09.2026 at its website.Material DetailsContext by AI AnalystThis is a routine disclosure signaling imminent release of financial de
NEWS | Sep 30, 2026, 10:46 AM UTC